drugset / Trial / NCT01929954
Safety Study of Gintuit™ in Subjects Requiring Socket Grafting
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a prospective, randomized, controlled, parallel group Phase 1/2 assessment of the safety of GINTUIT versus Bio-Gide in subjects who have a posterior tooth requiring extraction. The incidence and severity of adverse events will be summarized by group (GINTUIT and Bio-Gide).
Timeline
- Start
- 2013-07
- Primary completion
- 2015-03
- Completion
- 2015-03
Outcome
Outcome not reported
Stopped (Business): “Changes in corporate business environment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gintuit | Unknown | — | — |
Indications
No indication recorded.